Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation

The treatment strategy in multiple myeloma (MM) is to get complete remission followed by high-dose chemotherapy and autologous Hematopoietic Stem Cell Transplantation (HSCT). Neoplastic Plasma Cells (NPCs) are CD45(−/dim), CD38(+high), CD138(+), CD19(−), and  CD56(+high) in most cases. The descripti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dal Bó, Suzane, Pezzi, Annelise, Amorin, Bruna, Valim, Vanessa, Isabel Bittencourt, Rosane, Silla, Lucia
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3705753/
https://ncbi.nlm.nih.gov/pubmed/23864957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/847672
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares